SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $268,686 | 0.0% | 152,662 | 0.0% | 0.00% | – |
| Q1 2023 | $268,686 | -35.9% | 152,662 | +14.3% | 0.00% | – |
| Q4 2022 | $419,359 | -99.9% | 133,554 | 0.0% | 0.00% | – |
| Q3 2022 | $654,414,000 | +12.2% | 133,554 | -5.2% | 0.00% | – |
| Q2 2022 | $583,019,000 | -19.9% | 140,826 | +12.4% | 0.00% | – |
| Q1 2022 | $727,923,000 | -18.9% | 125,288 | +4.7% | 0.00% | – |
| Q4 2021 | $897,376,000 | +0.3% | 119,650 | +20.4% | 0.00% | – |
| Q3 2021 | $895,117,000 | -23.4% | 99,347 | +1.7% | 0.00% | -100.0% |
| Q2 2021 | $1,169,038,000 | -8.3% | 97,664 | -4.0% | 0.00% | 0.0% |
| Q1 2021 | $1,274,853,000 | -91.3% | 101,744 | -89.2% | 0.00% | -85.7% |
| Q4 2020 | $14,725,503,000 | +105.8% | 943,640 | +24.6% | 0.01% | +75.0% |
| Q3 2020 | $7,154,264,000 | +6.4% | 757,065 | +0.9% | 0.00% | 0.0% |
| Q2 2020 | $6,724,883,000 | +38.4% | 750,545 | -1.6% | 0.00% | +33.3% |
| Q1 2020 | $4,858,113,000 | -30.7% | 762,655 | -8.9% | 0.00% | -25.0% |
| Q4 2019 | $7,005,489,000 | -7.7% | 836,976 | -0.2% | 0.00% | -20.0% |
| Q3 2019 | $7,591,629,000 | -11.8% | 838,854 | +4.9% | 0.01% | -16.7% |
| Q2 2019 | $8,610,129,000 | +29.1% | 799,455 | +14.4% | 0.01% | +20.0% |
| Q1 2019 | $6,668,289,000 | -16.9% | 698,982 | 0.0% | 0.01% | -28.6% |
| Q4 2018 | $8,024,313,000 | -30.1% | 698,982 | +3.2% | 0.01% | -22.2% |
| Q3 2018 | $11,481,930,000 | +12.2% | 677,400 | -6.0% | 0.01% | +12.5% |
| Q2 2018 | $10,232,563,000 | -13.2% | 720,603 | +16.2% | 0.01% | -11.1% |
| Q1 2018 | $11,781,957,000 | +1835.3% | 620,103 | +1570.4% | 0.01% | +800.0% |
| Q4 2017 | $608,801,000 | +88.8% | 37,122 | +72.7% | 0.00% | – |
| Q3 2017 | $322,470,000 | +70.5% | 21,498 | 0.0% | 0.00% | – |
| Q2 2017 | $189,182,000 | +253.3% | 21,498 | +108.8% | 0.00% | – |
| Q1 2017 | $53,550,000 | +172641.9% | 10,298 | 0.0% | 0.00% | – |
| Q4 2016 | $31,000 | -77.2% | 10,298 | -65.0% | 0.00% | – |
| Q3 2016 | $136,000 | -20.0% | 29,398 | 0.0% | 0.00% | – |
| Q2 2016 | $170,000 | -4.5% | 29,398 | 0.0% | 0.00% | – |
| Q1 2016 | $178,000 | -93.8% | 29,398 | -90.6% | 0.00% | -100.0% |
| Q4 2015 | $2,855,000 | -9.9% | 312,665 | -44.3% | 0.00% | 0.0% |
| Q3 2015 | $3,167,000 | -45.0% | 561,414 | +8.2% | 0.00% | -50.0% |
| Q2 2015 | $5,757,000 | -29.6% | 519,096 | -0.5% | 0.01% | -25.0% |
| Q1 2015 | $8,180,000 | +2.5% | 521,698 | -0.6% | 0.01% | 0.0% |
| Q4 2014 | $7,980,000 | +195.7% | 524,698 | +109.6% | 0.01% | +166.7% |
| Q3 2014 | $2,699,000 | -26.4% | 250,298 | +4.2% | 0.00% | -25.0% |
| Q2 2014 | $3,669,000 | -15.6% | 240,298 | 0.0% | 0.00% | -20.0% |
| Q1 2014 | $4,345,000 | +41.8% | 240,298 | +8.9% | 0.01% | +25.0% |
| Q4 2013 | $3,064,000 | +33.5% | 220,598 | +0.7% | 0.00% | +33.3% |
| Q3 2013 | $2,295,000 | +34.2% | 218,998 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $1,710,000 | – | 218,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |